Article info
PDFLetter
Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey
- Correspondence to Dr Corrado Campochiaro, Università Vita-Salute San Raffaele, School of Medicine; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milano, Lombardia, Italy; campochiaro.corrado{at}hsr.it
Citation
Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey
Publication history
- Received December 28, 2020
- Revised January 9, 2021
- Accepted January 19, 2021
- First published January 28, 2021.
Online issue publication
April 04, 2023
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage